Pictet Asset Management (UK)’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
2015
Q1
$5.56M Sell
2014
Q4
$8.95M Buy
2014
Q3
$2.78M Sell
2014
Q2
$12.5M Buy
2014
Q1
$7.68M Sell
2013
Q4
$6.32M Sell
2013
Q3
$6.48M Sell
2013
Q2
$6.51M Buy